MaaT Pharma SA

EPA:MAAT.PA

7.52 (EUR) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -6.428-6.428-5.641-5.641-8.435-4.218-6.296-3.148-7.417-3.709-4.972-2.486-4.047-2.023-3.133-1.567-2.168-1.084
Depreciation & Amortization 0.8340.4170.3360.3110.20.0830.2430.1080.1860.0790.1830.080.1450.0640.1050.0390.0590.026
Deferred Income Tax 001.9140-2.0470.061.396-0.119-0.977000000000
Stock Based Compensation 0.4030.4030.2420.2420.1940.1940.2850.2850.140.140.2390.2390.1540.1540.0040.0040.0040.004
Change In Working Capital -0.388-0.3880.9580.958-5.088-2.0710.147-0.455-0.197-0.5890.4830.394-0.692-1.033-0.819-0.4430.0620.201
Accounts Receivables -0.404-0.4040.4120.412-0.478-0.2391.092-0.175-1.4130.0150.374-0.088-1.228-0.106-0.76400.3840
Change In Inventory 0.0060.006-0.058-0.058-0.028-0.0140.0180.009-0.032-0.016-0.017-0.017000000
Change In Accounts Payables -0.64502.7880-0.94701.05600.980001.374000-0.3390
Other Working Capital 0.6560.0110.6040.604-3.635-1.818-2.019-0.2890.268-0.5871.4830.499-0.838-0.927-0.394-0.4430.0170.201
Other Non Cash Items -0.725-0.3081.3091.3342.198-0.526-1.2960.481.0770.5070.628-0.0360.3820.6830.9610.0590.087-0.16
Operating Cash Flow -6.304-6.304-2.797-2.797-12.978-6.538-5.522-2.731-7.188-3.572-3.67-1.809-4.356-2.156-3.86-1.908-2.033-1.014
Investing Activities:
Investments In Property Plant And Equipment -0.063-0.063-0.307-0.307-0.574-0.24-0.591-0.296-0.071-0.0360.0180.009-0.256-0.128-0.254-0.144-0.062-0.014
Acquisitions Net 00-0.1390-0.09200000-0.06800.06800000
Purchases Of Investments -0.04900.0020-0.0020-0.090-0.10900000-0.178000
Sales Maturities Of Investments 00-0.00800.0220000000000000
Other Investing Activites 0.0830.0340.2360.2360.0910.091-0.022-0.022-0.055-0.055-0.034-0.0340.0340.034-0.072-0.072-0.017-0.017
Investing Cash Flow -0.03-0.03-0.072-0.072-0.555-0.149-0.681-0.318-0.18-0.09-0.049-0.025-0.189-0.095-0.432-0.216-0.062-0.031
Financing Activities:
Debt Repayment 00001.61900000-0.3410000000
Common Stock Issued 000.044012.54800.09100.011032.34300.09207.215010.7380
Common Stock Repurchased -0.017-0.009-0.029-0.029-0.022-0.011-0.045-0.023-0.092-0.04600000000
Dividends Paid 000000000000000000
Other Financing Activities 9.7779.777-5.038-2.507-0.7746.6171.4971.4971.2541.254-0.29415.829-0.145-0.0510.3775.16610.5125.254
Financing Cash Flow 9.7699.769-2.535-2.53513.3716.6063.0561.4752.4591.20831.70815.829-0.053-0.0510.3775.16610.5125.254
Other Information:
Effect Of Forex Changes On Cash 000.001000-0.001-36.82343.305000000000
Net Change In Cash -20.8453.435-10.806-5.404-0.162-0.081-3.148-38.396-4.908-2.45527.98913.995-4.598-2.36.0853.0438.4174.209
Cash At End Of Period 3.4353.43524.28-5.40435.086-0.08135.248038.396-2.45543.30429.3115.315-2.319.91316.8713.8274.209